Navigation Links
University Participating in West Nile Vaccine Trial

Vanderbilt University Medical Center researchers, in collaboration with investigators at Johns Hopkins University, are beginning a Phase I trial to test// a new vaccine against the West Nile virus.

The mosquito-borne virus, which can cause serious illness, is making its yearly appearance in Middle Tennessee. While no human cases of West Nile have been reported in the state so far this season, mosquitoes collected from around Nashville have tested positive for the virus.

"When West Nile virus first appeared in the United States five or six years ago, it spread remarkably quickly across the country," said Peter Wright, M.D., professor of Pediatrics, Microbiology and Immunology, and Pathology, who is heading up Vanderbilt's efforts in the trial. "There's no part of the country that has not experienced human and bird cases of West Nile."

Although around 80 percent of people infected by West Nile virus show no symptoms, up to 20 percent can experience moderate or severe symptoms ranging from fever, headaches and neck stiffness to neurological problems, paralysis and coma. About one in 150 people infected develop severe illness. People over the age of 50 are at the highest risk, but even healthy people can experience debilitating symptoms lasting several weeks.

There are currently no specific treatments or vaccines to combat West Nile infection, so those infected are consigned to letting the illness run its natural course.

While it is not clear who would most benefit from a West Nile vaccine, Wright suggests that it could be beneficial to certain high-risk populations, such as the elderly, people who work outside and have frequent exposure to mosquitoes, or those in specific geographic regions where West Nile cases are detected.

Finding an effective vaccine against West Nile could also open doors to developing vaccines for other insect-borne illnesses like Dengue fever, which are a priority for vaccin
'"/>




Page: 1 2

Related medicine news :

1. Researchers at Cornell University as been reported using research fund by false claims
2. A new study by John Hopkins University proposes formula for good health
3. James Cook University urges more medical seats
4. Pill splitting program of University of Michigan can save money
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Yale University guidelines for Physicians and Pharmaceutical industry
7. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
8. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
9. Hwang Woo Suk Suspended By Seoul National University
10. Vladeck to head the University of Medicine and Dentistry of New Jersey
11. Rice University wins Prestigious Grants from HHMI
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: University Participating West Nile Vaccine Trial

(Date:9/4/2015)... New York, NY (PRWEB) , ... September 04, 2015 , ... ... 400 meters qualifying heat, and followed up with victory in the men’s 400 meters ... Caribbean (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August ...
(Date:9/4/2015)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written an open ... upcoming trip to the United States. , Yisrayl lays out what he says is the ... society is. Yisrayl also provides the meaning of his own name and describes what bible ...
(Date:9/4/2015)... ... , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated their ... supporting families affected by autism, raising nearly $250,000. , 150 guests, including event ... Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings of ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud ... medicine is the norm not the exception. , St. Jude was recently named one ... Association/American Stroke Association, making it one of only 10 hospitals in the state to ...
(Date:9/3/2015)... ... ... William Mattar Law Offices is known for its slogan “Helping People, It’s ... certain demographic or segment of the population. Because of this, the firm will ... , The closed captioning will allow people with hearing impairments or who are deaf ...
Breaking Medicine News(10 mins):Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2
... improved planning of care and stronger relationships with physicians ... to a study by a Queen,s University professor. , ... every Canadian," says professor of Medicine and Epidemiology Daren ... Hospital. "But it,s not always happening. We know from ...
... WEDNESDAY, Oct. 27 (HealthDay News) --Mental health issues confronted ... Iraq and Afghanistan differ by gender, new research suggests. ... a diagnosis of depression than are their male counterparts, ... received health care from the Veterans Administration from 2002 ...
... Heidelberg, Germany, 27 October 2010 The European ... of outstanding research contributions by 63 life scientists ... life-long honour of EMBO membership, joining almost 1500 ... Members are the basis for the organization,s international ...
... a portable scanner based on radio frequency technology, which is able ... and benign in the breast on a computer. , Using ... proven by researchers in the US, Canada and UK. However, up ... to be produced, and this had to be done in a ...
... awarded six grants totaling approximately $12 million over ... fostering a diverse scientific workforce. The initiative, called ... Promote Diversity in the Scientific Workforce, is funded ... and administered by NIH,s National Institute of General ...
... News) -- Older adults who survive severe sepsis are at ... functioning, a new study indicates. This largely invisible problem ... burden on caregivers and families, as well as increasing the ... said. Also called "blood poisoning," sepsis is a potentially ...
Cached Medicine News:Health News:Mental Health Issues Differ for U.S. Male, Female Vets 2Health News:EMBO recognizes 63 researchers for advances in life sciences 2Health News:EMBO recognizes 63 researchers for advances in life sciences 3Health News:Portable breast scanner allows cancer detection in the blink of an eye 2Health News:NIH Recovery Act grants to foster scientific workforce diversity 2Health News:Brain Deficits Higher in Seniors Who Survive Blood Poisoning 2
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... TAMPA, Fla. , Sept. 3, 2015  WellCare ... that Drew Asher , senior vice president and ... Wells Fargo Securities 2015 Healthcare Conference on Wednesday, September ... The presentation will be webcast live. In addition, a ... conclusion of the live broadcast. Both the live broadcast ...
(Date:9/3/2015)... VIEJO, Calif. , Sept. 3, 2015 /PRNewswire/ ... global pharmaceutical company, and AqueSys, Inc. a private ... ocular implants that reduce intraocular pressure (IOP) associated ... into an agreement under which Allergan will acquire ... of the agreement, Allergan will acquire AqueSys for ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... PHILADELPHIA, May 23, 2011 Echo ... Symphony™ tCGM System as a non-invasive, wireless, transdermal ... SkinPrep System for transdermal drug delivery, announced that ... next generation Symphony tCGM System design.  This newly-engineered ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... The Lymphoma Pipeline: From Research and ... http://www.reportlinker.com/p0507256/A-Decision-Support-Tool-for-Optimizing-The-Lymphoma-Pipeline-From-Research-and-Development-to-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ...
Cached Medicine Technology:Echo Therapeutics Announces Symphony™ tCGM System Progress 2Echo Therapeutics Announces Symphony™ tCGM System Progress 3Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 2Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 3Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 4Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 5Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 6Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 7Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 8Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 9Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 10Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 11Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 12Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 13Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 14Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 15Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 16Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 17Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 18Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 19
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. Murphy eye. High volume/low pressure cuff. Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Steri...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
... rubber tube with Murphy eye. Laser resistant foam ... volume cuffs (One inside other) 40cm (16") long, ... allow maximum access and optimum visibility within the ... shaft has a special laser-guard of approx. 17cm ...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. S...
Medicine Products: